COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,584 Articles (22,905 medRxiv, 8,679 bioRxiv)

Most recent first Previous |  Page 1786: Articles 17851-17860  | Next

On the Environmental Determinants of COVID-19 Seasonality
Choi, Y.-W., Tuel, A., Eltahir, E. A. B.
10.1101/2021.03.01.21252243 — Posted: 2021-03-03
Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients
Antar, A. A. R., Yu, T., Pisnic, N., Azamfirei, R., Tornheim, J. A., Brown, D. M., Kruczynski, K., Hardick, J. P., Sewell, T., Jang, M., Church, T., Walch, S. N., Reuland, C., Bachu, V. S., Littlefield, K., Park, H.-S., Ursin, R. L., Ganesan, A., Kusemiju, O., Barnaba, B., Charles, C., Prizzi, M., Johnstone, J. R., Payton, C., Dai, W., Fuchs, J., Massaccesi, G., Armstrong, D. T., Townsend, J. L., Keller, S. C., Demko, Z. O., Hu, C., Wang, M.-C., Sauer, L. M., Mostafa, H. H., Keruly, J. C., Mehta, S. H., Klein, S. L., Cox, A. L., Pekosz, A., Heaney, C. D., Thomas, D. L., Blair, P. W., Manabe, Y. C.
10.1101/2021.03.02.21252420 — Posted: 2021-03-03
A single dose of SARS CoV 2 FINLAY FR 1A dimeric RBD recombinant vaccine enhances neutralization response in COVID19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial
Chang-Monteagudo, A., Ochoa-Azze, R., Climent-Ruiz, Y., Macias-Abraham, C., Rodriguez-Noda, L., Valenzuela-Silva, C., Sanchez-Ramirez, B., Perez-Nicado, R., Gonzalez-Mugica, R., Hernandez-Garcia, T., Orosa-Vazquez, I., Diaz-Hernandez, M., Garcia-Garcia, M. d. l. A., Jerez-Barcelo, Y., Triana-Marrero, Y., Ruiz-Villegas, L., Rodriguez-Prieto, L., Puga-Gomez, R., Guerra-Chaviano, P. P., Zuniga-Rosales, Y., Marcheco-Teruel, B., Rodriguez-Acosta, M., Noa-Romero, E., Enriquez-Puertas, J., Porto-Gonzalez, D., Leon-Monzon, K., Chen, G.-W., Herrera Martinez, L., Valdes-Balbin, Y., Garcia-Rivera, D., Verez-Bencomo, V.
10.1101/2021.02.22.21252091 — Posted: 2021-03-03
Genetic variation of IFNL4 is associated with COVID-19
Saponi-Cortes, J. M. R., Rivas, M. D., Sanchez Munoz-Torrero, J. F., Zamorano, J.
10.1101/2021.03.01.21252696 — Posted: 2021-03-03
Years of Life Lost Associated with COVID-19 Deaths in the United States During the First Year of the Pandemic
Quast, T., Andel, R., Gregory, S., Storch, E. A.
10.1101/2021.03.02.21252715 — Posted: 2021-03-03 Discussion: Onsite
State minimum wage, paid sick leave, and food insufficiency during the COVID-19 pandemic
Raifman, J., Nsoesie, E., Dean, L. T., Gutierrez, K., Raderman, W., Skinner, A., Shafer, P.
10.1101/2021.03.01.21252723 — Posted: 2021-03-03
redBERT: A Topic Discovery and Deep SentimentClassification Model on COVID-19 OnlineDiscussions Using BERT NLP Model
Pandey, C.
10.1101/2021.03.02.21252747 — Posted: 2021-03-03
Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalized health-care workers: a 90-day follow-up study
Nielsen, K. J., Vestergaard, J. M., Schlünssen, V., Bonde, J. P., Kaspersen, K. A., Biering, K., Carstensen, O., Greve, T., Hansen, K. K., Dalboge, A., Flachs, E. M., Jespersen, S., Hansen, M. L., Mikkelsen, S., Thomsen, M. K., Redder, J. D., Würtz, E. T., Ostergaard, L., Erikstrup, C., Kolstad, H. A.
10.1101/2021.03.02.21252437 — Posted: 2021-03-03
Recent changes in COVID-19 Vaccine Hesitancy among Healthcare Workers
OBrien, E. C., Xu, H., Cohen, L. W., Shenkman, E. A., Rothman, R. L., Forrest, C. B., Hernandez, A. F.
10.1101/2021.03.01.21252457 — Posted: 2021-03-03
COVID-19 Mortality in California Based on Death Certificates: Disproportionate Impacts Across Racial/Ethnic Groups and Nativity
Garcia, E., Eckel, S. P., Chen, Z., Li, K., Gilliland, F.
10.1101/2021.03.01.21252678 — Posted: 2021-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).